Veraxa Biotech names Raju Willener as CFO

• Veraxa Biotech appointed Raju Willener as chief financial officer, effective immediately, reporting to CEO Christoph Antz.
• Willener previously served as director of corporate development at Exentis Group, then became CFO in 2025.
• Carl von Halem stepped down as CFO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609040700PRIMZONEFULLFEED1001260942) on September 04, 2026, and is solely responsible for the information contained therein.